News Conference News AHA 2024 GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes Michael O'Riordan November 17, 2024
News Conference News EACTS 2024 MACE in CV Trials: Has the Outcome Outlived Its Role? Yael L. Maxwell October 11, 2024
News Daily News Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB Yael L. Maxwell June 14, 2024
News Conference News EuroPCR 2024 POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival Yael L. Maxwell May 22, 2024
News Daily News Certain Periprocedural MIs Don’t Matter, New Data Allege Michael O'Riordan May 09, 2024